About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

[S,S]-Reboxetine Dose-Range Finding Trial

NCT00288652·79 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients must have pain present for more than 3 months after the healing of shingles skin rash
Patients at screening must have a score \>/=40 mm on the pain visual analogue scale

You may not be if

Patients with significant renal and hepatic impairment
Patients with other severe pain, that may impair the self-assessment of the pain due to shingles
Patients with clinically abnormal electrocardiogram

The record

StatusCompleted

PhasePhase 2

Taking part280

StartedMar 2006

UpdatedJun 8, 2011

Conditions

Where79

Pfizer Investigational Site
Huntsville, Alabama, United States
Pfizer Investigational Site
Chandler, Arizona, United States
Pfizer Investigational Site
Mesa, Arizona, United States

Clareo Health | [S,S]-Reboxetine Dose-Range Finding Trial